rs1085307946
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM2PP3_StrongPP5_Moderate
The NM_000138.5(FBN1):c.2677+5G>C variant causes a splice region, intron change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
NM_000138.5 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:1
The c.2677+5 G>C variant has not been reported as a disease-causing variant or as a benign polymorphism to our knowledge. However, a different nucleotide substitution at the same position (c.2677+5 G>A) has been reported in a Taiwanese patient who met Ghent criteria for Marfan syndrome (Hung et al., 2009). In silico splice prediction algorithms predict c.2677+5 G>C damages the natural splice donor site in intron 22 and causes abnormal gene splicing. Other splice site variants in the FBN1 gene have been reported in HGMD in association with FBN1-related disorders (Stenson P et al., 2014). Furthermore, the c.2677+5 G>C variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations.Therefore, this variant is a strong candidate for a pathogenic mutation, however the possibility that it is a benign variant cannot be excluded -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at